Investec Asset Management LTD Has $7.49 Million Holdings in Stryker Corporation (SYK)
Investec Asset Management LTD boosted its stake in shares of Stryker Corporation (NYSE:SYK) by 35.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,755 shares of the medical technology company’s stock after buying an additional 13,740 shares during the period. Investec Asset Management LTD’s holdings in Stryker were worth $7,492,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of SYK. Acrospire Investment Management LLC purchased a new stake in shares of Stryker during the 2nd quarter valued at $111,000. Motco lifted its holdings in shares of Stryker by 50.7% during the 2nd quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares during the last quarter. Bruderman Asset Management LLC purchased a new stake in shares of Stryker during the 2nd quarter valued at $150,000. James Investment Research Inc. purchased a new stake in shares of Stryker during the 2nd quarter valued at $155,000. Finally, BB&T Investment Services Inc. purchased a new stake in shares of Stryker during the 2nd quarter valued at $178,000. Institutional investors own 74.97% of the company’s stock.
SYK has been the subject of several analyst reports. BidaskClub upgraded Stryker from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Zacks Investment Research lowered Stryker from a “buy” rating to a “hold” rating in a research note on Thursday, August 17th. Oppenheimer restated a “hold” rating on shares of Stryker in a research note on Wednesday, August 23rd. Canaccord Genuity restated a “buy” rating and issued a $155.00 target price (down previously from $158.00) on shares of Stryker in a research note on Thursday, August 24th. Finally, Piper Jaffray Companies restated an “overweight” rating and issued a $148.00 target price on shares of Stryker in a research note on Thursday, August 24th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $152.10.
Stryker Corporation (NYSE SYK) traded down $0.13 on Friday, reaching $155.87. 1,263,863 shares of the company’s stock were exchanged, compared to its average volume of 1,181,502. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.37 and a quick ratio of 1.61. Stryker Corporation has a twelve month low of $111.22 and a twelve month high of $160.62. The stock has a market cap of $58,330.00, a price-to-earnings ratio of 24.69, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79.
Stryker (NYSE:SYK) last posted its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The firm had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter last year, the firm earned $1.39 EPS. The firm’s revenue for the quarter was up 6.1% on a year-over-year basis. sell-side analysts forecast that Stryker Corporation will post 6.47 EPS for the current year.
In related news, insider Lonny J. Carpenter sold 5,000 shares of Stryker stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now owns 83,207 shares in the company, valued at approximately $12,925,375.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 7.40% of the stock is currently owned by company insiders.
COPYRIGHT VIOLATION NOTICE: This story was reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2017/12/01/investec-asset-management-ltd-has-7-49-million-holdings-in-stryker-corporation-syk.html.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.